Antithrombotic treatment for recurrent pregnancy loss?

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 1 S, 2011, Pages 302-305

  Greer, I A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Low dose aspirin; Low molecular weight heparin; Recurrent pregnancy loss; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

BODY MASS; DRUG DOSE COMPARISON; DRUG SAFETY; FETUS WASTAGE; GESTATIONAL AGE; HUMAN; LIVE BIRTH; LOW DRUG DOSE; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT PREGNANCY LOSS; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW (TOPIC); THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; ANTITHROMBINS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79960639216     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04313.x     Document Type: Review

References (20)

1. Younis J, Ohel G, Brenner B, Ben-Ami M. Familial thrombophilia - the scientific rationale for thromboprophylaxis in recurrent pregnancy loss? Hum Reprod 1997; 12: 1389-90.
2. Farquharson R, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomised controlled trial of treatment. Obstet Gynecol 2002; 100: 408-13.
3. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-7.
4. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005; 132: 171-96.
5. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update 2008; 14: 623-45.
6. Greer IA, Nelson-Piercy C. Low-molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review. Blood 2005; 106: 401-7.
7. Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J. For the LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX Study. J Thromb Haemost 2005; 3: 227-9.
8. Gris JC, Mercier E, Quéré I, Lavigne- Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland ML, Dauzat M, Mares P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a consti- tutional thrombophilic disorder. Blood 2004; 103: 3695-9.
9. Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006; 86: 362.
10. Visser J, Ulander VM, Helmerhorst FM, Lampinen K, Morin-Papunen L, Bloemenkamp KW, Kaaja RJ. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost 2011; 105: 295-301.
11. Coppens M, van Mourik JA, Eckmann CM, Büller HR, Middeldorp S. Current practice of testing for hereditary thrombophilia in the Netherlands. J Thromb Haemost 2007; 5: 1979-8.
12. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140-6.
13. Badawy AM, Khiary M, Sherif LS, Hassan M, Ragab A, Abdelall I. Low- molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J Obstet Gynaecol 2008; 28: 280-4.
14. Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet 2008; 278: 33-8.
15. Middeldorp S. Low-molecular-weight heparins have no place in recurrent miscarriage. Thromb Res 2011; 127 (Suppl. 3): S105-9.
16. Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyak K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DN, Büller HR, van der Veen F, Middeldorp S. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362: 1586-96.
17. Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, hague W, Rosene Montella K, Greer I. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008; 112: 320-4.
18. Greer IA. Antithrombotic therapy for recurrent miscarriage? N Engl J Med 2010; 362: 1630-1.
19. Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M, Whyte S, Greer IA. SPIN: the Scottish Pregnancy Intervention Study: a multicentre randomised controlled trial of low molecular weight heparin and low dose aspirin in women with recurrent miscarriage. Blood 2010; 115: 4162-7.
20. Qublan H, Amarin Z, Dabbas M, Farraj AE, Beni-Merei Z, Al-Akash H, Bdoor AN, Nawasreh M, Malkawi S, Diab F, Al-Ahmad N, Balawneh M, Abu-Salim A. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb) 2008; 11: 246-53.